Terms: = Lung cancer AND BCL9, LGS, 607, ENSG00000116128, MGC131591 AND Clinical Outcome
2 results:
1. Predictive and Prognostic Value of CYFRA 21-1 for Advanced Non-small Cell lung cancer Treated with EGFR-TKIs.
Takeuchi A; Oguri T; Sone K; Ito K; Kitamura Y; Inoue Y; Asano T; Fukuda S; Kanemitsu Y; Takakuwa O; Ohkubo H; Takemura M; Maeno K; Ito Y; Niimi A
Anticancer Res; 2017 Oct; 37(10):5771-5776. PubMed ID: 28982900
[TBL] [Abstract] [Full Text] [Related]
2. First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study.
Gatzemeier U; von Pawel J; Vynnychenko I; Zatloukal P; de Marinis F; Eberhardt WE; Paz-Ares L; Schumacher KM; Goddemeier T; O'Byrne KJ; Pirker R
Lancet Oncol; 2011 Jan; 12(1):30-7. PubMed ID: 21169060
[TBL] [Abstract] [Full Text] [Related]